Fully implantable trial results due QI, good results will see a re rate , EU sales ramp up progress news due, a market cap $105 million, available cash $55m , $40m in available finance ,lowest price target $14???, have faith , we are in good shape , only problem the share price $6, Buy.
Fully implantable trial results due QI, good results will see a...
Add to My Watchlist
What is My Watchlist?